{"schema_version":"secwatch.filing_event.v1","accession":"0000064803-24-000009","form_type":"8-K","ticker":"CVS","cik":"0000064803","company_name":"CVS HEALTH Corp","filed_at":"2024-03-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.673265+00:00","generated_at":"2026-06-05T04:21:54.969485+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"CVS Health reiterates FY2024 guidance: GAAP EPS ≥$7.06, adjusted ≥$8.30","bullets":["Reaffirmed FY2024 GAAP diluted EPS guidance of at least $7.06.","Reaffirmed FY2024 Adjusted EPS guidance of at least $8.30.","Reaffirmed FY2024 cash flow from operations guidance of at least $12.0 billion.","CFO Tom Cowhey to discuss business trends at March 5 webcast.","Guidance unchanged; no new financial information provided."],"urls":{"canonical":"https://secwatch.observer/filing/0000064803-24-000009","json":"https://secwatch.observer/filing/0000064803-24-000009.json","markdown":"https://secwatch.observer/filing/0000064803-24-000009.md","text":"https://secwatch.observer/filing/0000064803-24-000009.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/64803/000006480324000009/0000064803-24-000009-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/64803/000006480324000009/cvs-20240305.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T04:21:54.969485+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}